U
PFE icon

UBS’s Pfizer PFE Stock Holding History

UBS’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$532M Buy
18,946,615
+1,464,015
+8% +$41.1M 0.39% 35
2014
Q2 		$492M Buy
17,482,600
+1,090,629
+7% +$31.1M 0.39% 34
2014
Q1 		$500M Buy
16,391,971
+3,867,441
+31% +$115M 0.44% 27
2013
Q4 		$364M Sell
12,524,530
-1,373,757
-10% -$40M 0.34% 47
2013
Q3 		$379M Buy
13,898,287
+2,012,643
+17% +$54.8M 0.39% 40
2013
Q2 		$316M Buy
+11,885,644
New +$328M 0.37% 41

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS's PFE Position: Q3 2014 in Review

UBS increased its Pfizer (PFE) stake by 8.4% in Q3 2014, buying an estimated $41.1M and bringing the position to 18,946,615 shares worth $532M. The position accounts for 0.39% of the portfolio, ranked #35.

UBS first reported a position in PFE in Q2 2013 and has held it in 6 quarters since. 1,742 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • UBS held 18,946,615 shares of Pfizer worth $532M as of Q3 2014.
  • UBS bought 1,464,015 Pfizer shares in Q3 2014, an estimated $41.1M.
  • Pfizer made up 0.39% of UBS's portfolio in Q3 2014, its #35 holding.
  • UBS first reported a position in Pfizer in Q2 2013 and has held it in 6 quarters since.
  • 1,742 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.